The impact of ERBB2 alterations in muscle-invasive bladder cancer after neoadjuvant chemotherapy. Burgess EF, Elom H, Brown LC, McCormack M, et al. BJUI Compass 2026;7:e70274.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Burgess EF, Elom H, Brown LC, McCormack M, et al. The impact of ERBB2 alterations in muscle-invasive bladder cancer after neoadjuvant chemotherapy. BJUI Compass 2026;7:e70274.
PMID: 42605443